The estimated Net Worth of Catalyst Group Management H... is at least $2.24 Bilhão dollars as of 11 May 2020. Catalyst H owns over 300,000 units of Livongo Health stock worth over $2,228,383,300 and over the last 5 years Catalyst sold LVGO stock worth over $15,864,000.
Catalyst has made over 1 trades of the Livongo Health stock since 2020, according to the Form 4 filled with the SEC. Most recently Catalyst sold 300,000 units of LVGO stock worth $15,864,000 on 11 May 2020.
The largest trade Catalyst's ever made was selling 300,000 units of Livongo Health stock on 11 May 2020 worth over $15,864,000. On average, Catalyst trades about 50,000 units every 0 days since 2020. As of 11 May 2020 Catalyst still owns at least 15,943,216 units of Livongo Health stock.
You can see the complete history of Catalyst H stock trades at the bottom of the page.
Over the last 5 years, insiders at Livongo Health have traded over $82,400,328 worth of Livongo Health stock and bought 11,181,508 units worth $313,072,144 . The most active insiders traders include Hemant Taneja, Joel E Cutler, eGlen Tullman. On average, Livongo Health executives and independent directors trade stock every 12 days with the average trade being worth of $49,555,733. The most recent stock trade was executed by Philip D Green on 27 October 2020, trading 85,415 units of LVGO stock currently worth $135,810.
Livongo Health, Inc. engages in the development and operation of consumer digital health platform. It offers Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company was founded by Kimon Angelides and Glen E. Tullman on October 16, 2008 and is headquartered in Mountain View, CA.
Livongo Health executives and other stock owners filed with the SEC include: